Company intelligence / Profile preview

The Star

South San Francisco, California, United States

Ownership: Private
Employees: ~50
Development stage: Other

Overview

Star Therapeutics is a biotechnology company that functions as a venture studio and holding company to develop a portfolio of first-in-class antibody therapies. The company utilizes its proprietary Star Engine platform to identify high-impact targets in areas of significant unmet medical need, particularly in rare diseases and oncology. Star Therapeutics operates through a decentralized model, spinning out independent companies such as Electra Therapeutics and Vega Therapeutics to advance specific programs. Their lead programs focus on modulating immune cell activity and coagulation pathways to treat life-threatening inflammatory and hematologic conditions.

Therapeutic areas: HematologyImmunologyOncology
Modalities: Monoclonal antibodyAntibody
Industry: Biotech

Beyond the preview

Go deeper on The Star.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on The Star.

Explore the full profile